Effect of levocarnitine on maintainance hemodialysis in patients with hypotension
10.3969/j.issn.1005-1678.2016.04.24
- VernacularTitle:左卡尼汀对维持性血液透析低血压患者的临床疗效观察
- Author:
Min HUANG
;
Chunqin YANG
- Publication Type:Journal Article
- Keywords:
hemodialysis;
levocarnitine;
hypotension;
clinical curative effect
- From:
Chinese Journal of Biochemical Pharmaceutics
2016;36(4):83-85
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate effect of levocarnitine on maintainance hemodialysis in patients with hypotension.Methods 64 cases with continuous hemodialysis hypotension were randomly divided into control group and treatment group, 32 cases in each group.Patients in the control group were treated with erythropoietin treatment after regular hemodialysis, and the treatment group based on the control group with levocarnitine.Blood pressure, hemoglobin, urea clearance rate, hypotension and changes of C-reactive protein (CRP), arteriovenous fistula occlusion and cardiovascular events incidence were compared after the treatment.Results Compared with before treatment, the incidence of two groups of blood pressure and hemoglobin levels were significantly increased ( P <0.05 ) and CRP levels decreased ( P <0.05 ) , hypotension, arteriovenous fistula occlusion and cardiovascular events rate were decreased (P<0.05); compared with the control group, systolic blood pressure and minimum systolic blood pressure and hemoglobin levels of treatment group were higher (P<0.05) and CRP levels were lower (P<0.05), the incidence of hypotension, arteriovenous fistula occlusion and cardiovascular events were lower (P<0.05), the clinical curative effect was higher (P<0.05).Conclusion Levocarnitine can effectively reduce the occurrence of hypotension in hemodialysis patients continuously, with good clinical efficacy and safety.
